Willar v. Esper, Secretary

CourtDistrict Court, D. Maryland
DecidedNovember 18, 2020
Docket1:19-cv-02785
StatusUnknown

This text of Willar v. Esper, Secretary (Willar v. Esper, Secretary) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Willar v. Esper, Secretary, (D. Md. 2020).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND

MARK WILLAR,

Plaintiff,

v. Civil Action No.: GLR-19-2785

MARK T. ESPER, Ph.D., in his official capacity as Secretary, Department of Defense,

Defendant.

MEMORANDUM OPINION

THIS MATTER is before the Court on the Motion to Dismiss, or in the Alternative, for Summary Judgment by Defendant Mark T. Esper, Ph.D., in his official capacity as Secretary, Department of Defense (“DoD”) (ECF No. 11).1 The Motion is ripe for disposition, and no hearing is necessary. See Local Rule 105.6 (D.Md. 2018). For the reasons set forth below, the Court will deny the Motion. I. BACKGROUND2 A. Factual Background In November 2016, Plaintiff Mark Willar accepted a job offer from the Missile Defense Agency (“MDA”), a research, development, and acquisition agency within the

1 For reasons set forth below, the Court will construe the Motion as a motion to dismiss. For the same reasons, the Court will grant Plaintiff Mark Willar’s pending Motion for Discovery (ECF No. 15). 2 Unless otherwise noted, the Court takes the following facts from Willar’s Complaint and accepts them as true. See Erickson v. Pardus, 551 U.S. 89, 94 (2007) (citations omitted). DoD, to work at an Elkton, Maryland manufacturing facility as an MDA Assurance Representative (“MAR”). (Compl. ¶¶ 6, 20, 23, ECF No. 1). At the time, the Elkton facility

was owned and operated by a company known as Orbital ATK. (Id. ¶ 20). In the role for which Willar was hired, he expected to “oversee the quality assurance of the missile defense system hardware components that Orbital ATK developed, tested, and manufactured for MDA under contract with the Department of Defense.” (Id. ¶ 21). Willar initially reported to Kevin Sheahan, MDA’s Quality Safety Integration Chief, and his second-line supervisor was Michael Wadzinski, MDA’s Director of Quality and Safety.

(Id. ¶¶ 22, 25). Willar suffers from Reactive Airway Dysfunction Syndrome (“RADS”), a lung disease that impairs his breathing. (Id. ¶ 8). RADS “substantially limits Willar’s lung capacity and pulmonary function, and as a result, his breathing, in all areas of his life.” (Id. ¶ 10). RADS impairs Willar’s ability to take stairs, carry heavy objects, exercise, or play

sports. (Id. ¶¶ 11–13). Willar relies on an inhaler and a respirator to mitigate the effects of RADS. (Id. ¶¶ 14–15). In particular, “Willar must use a respirator to protect his lungs from airborne irritants in certain settings, including in the manufacturing plants in which he has worked.” (Id. ¶ 15). Willar’s employment with MDA began on February 19, 2017. (Id. ¶ 24). Five days

beforehand, Willar requested and Sheahan approved a compressed work schedule, under which Willar would work nine-hour shifts Monday through Thursday and take off every other Friday. (Id. ¶ 26). Three days before beginning employment, Willar notified Sheahan that he suffers from RADS and requested to use a respirator at work as an accommodation for his disability. (Id. ¶ 27). Willar also requested the material safety data sheets (“MSDS”) for the Elkton facility—documents that “list the respiratory irritants, chemical

compositions, and safety requirements”—which would enable him to ensure he used the correct filter in his respirator. (Id. ¶ 29). Sheahan responded by emailing MDA’s Equal Opportunity Assistant, copying Wadzinski and Thomas Fisher, MDA’s Deputy for Quality Safety Inspection,3 stating that “Willar just disclosed to MDA today (see below) that he has a medical condition. He did not disclose this prior to today. . . . I personally believe this candidate was not up-front with

MDA.” (Id. ¶ 30). In response, Fisher wrote: “?????????????????? - how could he apply for a position at Orbital ATK, a site that manufactures freaken [sic] solid rocket motors with a lung condition? . . . ahhhhhhhhhhhhhhhhhhhhhhhhhhhh!!!!!!!!!!!!” (Id. ¶ 32). On February 17, 2017, Sheahan asked Willar to provide information about the respirator he owned so that MDA could “check with Orbital-ATK to see if it is permitted

in their Elkton MD manufacturing spaces.” (Id. ¶ 33). Willar provided the information. (Id. ¶ 34). In response to Willar’s request for MSDS files, Sheahan wrote that Orbital ATK uses “100’s of different chemical[s]” and that the quantity of corresponding MSDS files would be “several inches thick.” (Id. ¶ 36). Later that day, Sheahan again wrote to Fisher, asserting that he was “amazed he [Willar] even applied for this position. It’s only the worst

case manuf [sic] plant wrt [sic] chemicals, in the world, that MDA does business in.” (Id. ¶ 38).

3 Fisher previously served as the MAR at the Elkton facility. Fisher then wrote to Jim Tedesco, Orbital ATK’s Director of Safety and Security for Missile Defense and Controls at the Elkton facility, and asked leading questions about

the ability to accommodate Willar’s need for a respirator, including: 1. Will OA [Orbital ATK] not allow Willar to use his personal respirator during manufacturing surveillance of MDA product due to liability concerns in OA manufacturing and test areas? . . .

2. Will OA not allow Mr Willar to use his personal respirator due to product risks at the OA site? For example, is respirator use a product contamination hazard? 3. Will OA Elkton, MD not allow Mr Willar to wear this personal respirator due to safety concerns at the OA site? . . .

(Id. ¶ 42) (emphasis added in Complaint). In response, Tedesco adopted the language used by Fisher in his email, stating that “Orbital ATK would not allow Willar to wear his personal respirator, brand and model number 3M 7502/37082 . . . due to ‘product safety’ and ‘personnel safety’ concerns.” (Id. ¶ 43). Willar notes in his Complaint that he never insisted on using any particular respirator. (Id. ¶ 44). Tedesco further asserted that a silicone respirator like Willar used was unacceptable “‘due to the risk of product contamination from the silicone material’ and because of the ‘replaceable piece parts on the mask.’” (Id. ¶ 46). Willar notes, however, that “Orbital ATK allows its own employees to use silicone respirators with replaceable parts throughout the Elkton facility.” (Id.). Regardless, on February 28, 2017, Fisher wrote to Sheahan and stated in unambiguous terms that “Willar is (now) not a [Quality Safety Inspection] employee due to his latent medical disclosure.” (Id. ¶ 49). The following day, Sheahan emailed Willar and told him that MDA was requiring him to undergo a medical evaluation by the U.S. Department of Health and Human Services’ Federal Occupational Health (“FOH”) Program to assess his disability. (Id. ¶ 55). Willar authorized his physician to

provide information to the FOH Program. (Id. ¶ 56). On March 6, 2017, Wadzinksi placed Willar on what he described as a “temporary” detail to an office in Dahlgren, Virginia, approximately 150 miles from Willar’s home, pending resolution of Willar’s request for an accommodation. (Id. ¶¶ 57–58). “Sheahan described the detail as an ‘estimated 2-week trip to our offices in Dahlgren VA[.]’” (Id. ¶ 59). The following day, Willar emailed Sheahan to request additional information about

other options for his temporary detail, the duration of the temporary assignment, and the FOH assessment, but did not receive a response. (Id. ¶ 63). Due to the distance between his home and Dahlgren, Willar was forced to make arrangements to stay in a hotel in Dahlgren during the week. (Id. ¶ 66). According to Willar, “[t]his arrangement disrupted all aspects of [his] personal life and prevented him from attending worship services,

maintaining personal relationships, and participating in social and recreational activities during the week” and “negatively impacted his diet and sleep patterns.” (Id. ¶ 67).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Scheuer v. Rhodes
416 U.S. 232 (Supreme Court, 1974)
Chandler v. Roudebush
425 U.S. 840 (Supreme Court, 1976)
Albright v. Oliver
510 U.S. 266 (Supreme Court, 1994)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Harrods Limited v. Sixty Internet Domain Names
302 F.3d 214 (Fourth Circuit, 2002)
Dorn B. Holland v. Washington Homes, Incorporated
487 F.3d 208 (Fourth Circuit, 2007)
Bizzie Walters v. Todd McMahen
684 F.3d 435 (Fourth Circuit, 2012)
Moret v. Harvey
381 F. Supp. 2d 458 (D. Maryland, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
Willar v. Esper, Secretary, Counsel Stack Legal Research, https://law.counselstack.com/opinion/willar-v-esper-secretary-mdd-2020.